Earnings Feed
Start Free
Home/Insiders/Bourdow Carrie L.
BC
SEC Insider//CIK 0001638989

Bourdow Carrie L.

CIK 00016389894 companiesKING OF PRUSSIA, PA
SEC Profile

Transactions

50

Companies

4

Filings

11

CIK

0001638989

Recent Transactions

50 trades
  • Tax Payment
    TREVENA INC

    Common Stock

    2024-10-08$1.47/sh−143→ 25,519 total
  • Tax Payment
    TREVENA INC

    Common Stock

    2024-10-08$1.47/sh−285→ 24,949 total
  • Tax Payment
    TREVENA INC

    Common Stock

    2024-10-08$1.47/sh−1,055→ 23,894 total
  • Tax Payment
    TREVENA INC

    Common Stock

    2024-10-08$1.47/sh−54→ 25,662 total
  • Tax Payment
    TREVENA INC

    Common Stock

    2024-10-08$1.47/sh−285→ 25,234 total
  • Tax Payment
    TREVENA INC

    Common Stock

    2023-12-14$0.61/sh−7,123→ 642,923 total
  • Award
    TREVENA INC

    Common Stock

    2023-12-14$0.61/sh+370,000→ 550,046 total
  • Award
    TREVENA INC

    Common Stock

    2023-12-14$0.61/sh+100,000→ 650,046 total
  • Tax Payment
    TREVENA INC

    Common Stock

    2023-12-02$0.59/sh−1,343→ 190,731 total
  • Tax Payment
    TREVENA INC

    Common Stock

    2023-12-02$0.59/sh−7,123→ 180,046 total
  • Tax Payment
    TREVENA INC

    Common Stock

    2023-12-02$0.59/sh−3,562→ 187,169 total
  • Award
    TREVENA INC

    Common Stock

    2023-01-06+100,000→ 192,074 total
  • Tax Payment
    TREVENA INC

    Common Stock

    2022-12-17$1.55/sh−1,342→ 92,074 total
  • Tax Payment
    TREVENA INC

    Common Stock

    2022-12-02$3.42/sh−3,560→ 93,416 total
  • Sale
    Nabriva Therapeutics plc

    Ordinary Shares

    2022-08-01$0.17/sh−8,540→ 9,933 total
  • Award
    Carisma Therapeutics Inc.$CARM

    Common Stock

    2022-06-22+40,000→ 40,000 total
  • Award
    Carisma Therapeutics Inc.$CARM

    Stock Option

    2022-06-22+65,000→ 65,000 total
  • Tax Payment
    TREVENA INC

    Common Stock

    2021-12-17$0.70/sh−33,546→ 2,424,403 total
  • Tax Payment
    TREVENA INC

    Common Stock

    2021-12-06$0.65/sh−93,561→ 2,457,949 total
  • Award
    TREVENA INC

    Common Stock

    2021-12-02+1,250,000→ 2,551,510 total
  • Sale
    Nabriva Therapeutics plc

    Ordinary Shares

    2021-08-02$1.20/sh−777→ 18,473 total
  • Award
    Nabriva Therapeutics plc

    Share Options

    2021-07-28+35,000→ 35,000 total
  • Award
    Nabriva Therapeutics plc

    Ordinary Shares

    2021-07-28+17,500→ 19,250 total
  • Purchase
    TREVENA INC

    Common Stock

    2021-06-28$1.79/sh+56,200→ 1,301,510 total
  • Award
    Carisma Therapeutics Inc.$CARM

    Stock Option

    2021-05-03+92,500→ 92,500 total
  • Award
    TREVENA INC

    Stock Option (Right to Buy)

    2020-12-17+706,650→ 706,650 total
  • Award
    TREVENA INC

    Common Stock

    2020-12-17+471,100→ 1,264,060 total
  • Tax Payment
    TREVENA INC

    Common Stock

    2020-12-07$2.27/sh−132,934→ 792,960 total
  • Tax Payment
    TREVENA INC

    Common Stock

    2020-12-07$2.27/sh−151,684→ 1,245,310 total
  • Award
    Nabriva Therapeutics plc

    Stock Options

    2020-07-29+35,000→ 35,000 total
  • Award
    Nabriva Therapeutics plc

    Ordinary Shares

    2020-07-29+17,500→ 17,500 total
  • Award
    Carisma Therapeutics Inc.$CARM

    Stock Option

    2020-05-06+59,000→ 59,000 total
  • Award
    Carisma Therapeutics Inc.$CARM

    Stock Option

    2020-02-24+118,000→ 118,000 total
  • Award
    TREVENA INC

    Common Stock

    2019-12-12+657,000→ 925,894 total
  • Tax Payment
    TREVENA INC

    Common Stock

    2019-12-02$0.69/sh−17,804→ 268,894 total
  • Award
    TREVENA INC

    Stock Option (Right to Buy)

    2019-09-19+250,000→ 250,000 total
  • Award
    Nabriva Therapeutics plc

    Stock Option

    2019-07-31+35,000→ 35,000 total
  • Tax Payment
    TREVENA INC

    Common Stock

    2019-06-03$1.17/sh−17,802→ 286,698 total
  • Award
    TREVENA INC

    Common Stock

    2019-02-01$1.02/sh+50,000→ 304,500 total
  • Award
    TREVENA INC

    Employee Stock Option (Right to Buy)

    2018-12-06+250,000→ 250,000 total
  • Award
    TREVENA INC

    Common Stock

    2018-12-06+250,000→ 254,500 total
  • Award
    TREVENA INC

    Employee Stock Option (Right to Buy)

    2018-09-27+335,000→ 335,000 total
  • Award
    Nabriva Therapeutics plc

    Stock Option

    2018-05-02+29,000→ 29,000 total
  • Award
    TREVENA INC

    Employee Stock Option (Right to Buy)

    2018-02-28+112,500→ 112,500 total
  • Award
    TREVENA INC

    Employee Stock Option (Right to Buy)

    2018-02-28+124,000→ 124,000 total
  • Award
    Nabriva Therapeutics plc

    Stock Option

    2017-09-15+10,100→ 10,100 total
  • Award
    TREVENA INC

    Employee Stock Option (Right to Buy)

    2017-08-28+66,000→ 66,000 total
  • Award
    Nabriva Therapeutics plc

    Stock Option

    2017-07-31+20,200→ 20,200 total
  • Award
    TREVENA INC

    Employee Stock Option (Right to Buy)

    2017-03-02+91,000→ 91,000 total
  • Award
    TREVENA INC

    Employee Stock Option (Right to Buy)

    2017-01-06+55,000→ 55,000 total

Companies

4

Recent Filings

11

Address

C/O TREVENA, INC., 1018 WEST 8TH AVENUE, SUITE A

KING OF PRUSSIA, PA, 19406

View on SEC.gov